Sort   by:  
 Page size 
UnknownGenome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI).
Not available
S-EPMC10924947 | biostudies-literature
UnknownSocioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing.
Not available
S-EPMC11483106 | biostudies-literature
UnknownThe role of sphingosine-1-phosphate transporter Spns2 in immune system function.
Not available
S-EPMC3381845 | biostudies-literature
UnknownA global database of Holocene paleotemperature records.
Not available
S-EPMC7156486 | biostudies-literature
UnknownMammary intraepithelial lymphocytes and intestinal inputs shape T cell dynamics in lactogenesis.
Not available
S-EPMC12369998 | biostudies-literature
UnknownAllele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.
Not available
S-EPMC9154344 | biostudies-literature
UnknownLoss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma.
Not available
S-EPMC12659308 | biostudies-literature
UnknownCopy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Not available
S-EPMC10415299 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
Sort   by:  
 Page size